NRIX logo

Nurix Therapeutics, Inc. (NRIX)

Profile

Full Name

Nurix Therapeutics, Inc.

Ticker

NASDAQ: NRIX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 2020

Indexes

Not included

Website

https://www.nurixtx.com

Employees

286

Key Details

Price

$10.35(3.66%)

Market Cap

$790.87M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$54.55M(-29.15% YoY)

Annual EPS

-$2.88(-8.86% YoY)

PE Ratio

-

Next earnings date

Oct 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.35
    NRIX price is $10.35

    30-Day Relative Volume

    1.05
    NRIX 30-day relative volume is 1.05

    Price Performance

    Price 1-Day Change

    +3.66%
    NRIX price is up +3.66% today

    Price YTD Change

    -45.09%
    NRIX price is down -45.09% since January 1st

    Price 1-Year Change

    -52.96%
    NRIX price is down -52.96% year-on-year

    Price 3-Year Change

    -5.7%
    NRIX price is down -5.7% over the past 3 years

    Price Range

    Price All-Time High

    $52.38
    NRIX price is currently -80.25% below its historical high of $52.38

    Price 3-Year Low

    $4.22
    NRIX price is currently +145.14% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $790.87M
    NRIX market cap is $790.87 million

    Market Cap 3-Year Change

    +52.91%
    NRIX market cap is up +52.91% over the past 3 years

    Market Cap All-Time High

    $2.04B
    NRIX market cap is currently -61.17% below its historical high of $2.04 billion

    Market Cap Sector Percentile

    67.99%
    NRIX market cap is higher than 67.99% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +13.96%
    NRIX shares outstanding is up +13.96% year-on-year

    Shares Outstanding 3-Year Change

    +62.15%
    NRIX shares outstanding is up +62.15% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.30
    NRIX beta is 1.30

    200-day SMA

    $12.76
    NRIX price is currently -18.92% below its 200-day simple moving average

    50-day SMA

    $9.62
    NRIX price is currently +7.55% above its 50-day simple moving average

    14-Day RSI

    58.48
    NRIX 14-day relative strength index is 58.48

    Volume

    1.05
    NRIX 30-day relative volume is 1.05

    ATR

    $0.54
    NRIX average true range is $0.54

    10-day Historical Volatility

    60.50%
    NRIX 10-day historical volatility is 60.50%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $54.55M
    NRIX annual revenue is $54.55 million

    Revenue Analysts Estimate

    $91.75M
    NRIX annual revenue is currently -40.55% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -29.15%
    NRIX annual revenue is down -29.15% year-on-year

    Revenue Sector Percentile

    62.37%
    NRIX annual revenue is higher than 62.37% of companies in Healthcare sector

    EPS

    EPS

    -$2.88
    NRIX annual earnings per share is -$2.88

    EPS Analysts Estimate

    -$2.96
    NRIX annual earnings per share is currently +2.70% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -8.86%
    NRIX annual earnings per share is down -8.86% year-on-year

    EPS Sector Percentile

    31.17%
    NRIX annual earnings per share is higher than 31.17% of companies in Healthcare sector

    Profit

    Gross Profit

    $38.12M
    NRIX annual gross profit is $38.12 million

    Gross Margin

    69.88%
    NRIX annual gross profit margin is 69.88%

    Operating Profit

    -$213.03M
    NRIX annual operating income is -$213.03 million

    Operating Margin

    -390.52%
    NRIX annual operating profit margin is -390.52%

    Net Income

    -$193.57M
    NRIX annual net profit is -$193.57 million

    Net Margin

    -354.85%
    NRIX annual net profit margin is -354.85%

    Expenses

    Total Expenses

    $267.58M
    NRIX annual total expenses is $267.58 million

    Operating Expenses

    $267.58M
    NRIX annual total operating expenses is $267.58 million

    Cost Of Goods Sold

    $16.43M
    NRIX annual cost of goods sold is $16.43 million

    Selling, General & Administrative Expenses

    $45.94M
    NRIX annual SG&A is $45.94 million

    Depreciation & Amortization

    $16.43M
    NRIX annual D&A is $16.43 million

    Interest Expense

    $0.00
    NRIX annual interest expense is $0.00

    Income Tax

    $270.00K
    NRIX annual income tax is $270.00 thousand

    EBIT & EBITDA

    EBIT

    -$213.03M
    NRIX annual earnings before interest & taxes is -$213.03 million

    EBITDA

    -$196.60M
    NRIX annual EBITDA is -$196.60 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $675.43M
    NRIX annual total assets is $675.43 million

    Non Current Assets

    $49.96M
    NRIX annual long term assets is $49.96 million

    Current Assets

    $619.39M
    NRIX annual total current assets is $619.39 million

    Cash and Cash Equivalents

    $110.00M
    NRIX annual cash & cash equivalents is $110.00 million

    Accounts Receivable

    -
    NRIX annual accounts receivable value is unknown

    Inventory

    $0.00
    NRIX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $148.44M
    NRIX annual total liabilities is $148.44 million

    Long Term Liabilities

    $46.50M
    NRIX annual total long term liabilities is $46.50 million

    Current Liabilities

    $95.85M
    NRIX annual current liabilities is $95.85 million

    Accounts Payable

    $11.48M
    NRIX annual accounts payable is $11.48 million

    Debt

    Total Debt

    $28.30M
    NRIX annual total debt is $28.30 million

    Total Debt 1-Year Change

    -7.55%
    NRIX annual total debt is down -7.55% year-on-year

    Long Term Debt

    $20.29M
    NRIX annual long term debt is $20.29 million

    Short Term Debt

    $8.01M
    NRIX annual short term debt is $8.01 million

    Equity & Capital

    Shareholders Equity

    $526.99M
    NRIX annual stockholders equity is $526.99 million

    Book Value

    $526.99M
    NRIX annual book value is $526.99 million

    Retained Earnings

    -$738.77M
    NRIX annual retained earnings is -$738.77 million

    Working Capital

    $523.53M
    NRIX annual working capital is $523.53 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$172.58M
    NRIX annual cash from operations is -$172.58 million

    Cash From Operations 1-Year Change

    -112.11%
    NRIX annual cash from operations is down -112.11% year-on-year

    Cash From Investing

    -$257.71M
    NRIX annual cash from investing is -$257.71 million

    Cash From Investing 1-Year Change

    -477.32%
    NRIX annual cash from investing is down -477.32% year-on-year

    Cash From Financing

    $485.67M
    NRIX annual cash from financing is $485.67 million

    Cash From Financing 1-Year Change

    +14996.89%
    NRIX annual cash from financing is up +14996.89% year-on-year

    CAPEX

    CAPEX

    $9.27M
    NRIX annual capital expenditures is $9.27 million

    CAPEX 1-Year Change

    +10.38%
    NRIX annual capital expenditures is up +10.38% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$181.86M
    NRIX annual free cash flow is -$181.86 million

    Free Cash Flow 1-Year Change

    -102.59%
    NRIX annual free cash flow is down -102.59% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    69.88%
    NRIX annual gross profit margin is 69.88%

    Operating Margin

    -390.52%
    NRIX annual operating profit margin is -390.52%

    Net Margin

    -354.85%
    NRIX annual net profit margin is -354.85%

    ROA & ROE

    ROA

    -37.23%
    NRIX annual return on assets is -37.23%

    ROE

    -53.22%
    NRIX annual return on equity is -53.22%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    NRIX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    NRIX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.77
    NRIX price to book ratio is 1.77

    PB Ratio Sector Percentile

    46.03%
    NRIX price to book ratio is higher than 46.03% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    8.95
    NRIX price to sales ratio is 8.95

    PS Ratio Sector Percentile

    68.57%
    NRIX price to sales ratio is higher than 68.57% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $357.02M
    NRIX enterprise value is $357.02 million

    Enterprise Value Sector Percentile

    60.71%
    NRIX enterprise value is higher than 60.71% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.68
    NRIX EV/EBITDA is -1.68

    EV/EBITDA Sector Percentile

    42.07%
    NRIX EV/EBITDA is higher than 42.07% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    6.46
    NRIX annual current ratio is 6.46

    Quick Ratio

    6.46
    NRIX annual quick ratio is 6.46

    Leverage

    Debt To Equity

    0.00
    NRIX annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    NRIX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    2
    NRIX piotroski f-score is 2

    Altman Z-Score

    1.64
    NRIX altman z-score is 1.64

    Analyst ratings

    Recent major analysts updates

    Jul 31, 25 Oppenheimer
    Outperform
    Jul 15, 25 Morgan Stanley
    Equal-Weight
    Jul 14, 25 HC Wainwright & Co.
    Buy
    Jul 10, 25 UBS
    Buy
    Jul 10, 25 Stephens & Co.
    Overweight
    Jul 10, 25 Oppenheimer
    Outperform
    Apr 29, 25 Needham
    Buy
    Apr 9, 25 Wells Fargo
    Overweight
    Apr 9, 25 Stifel
    Buy
    Apr 9, 25 Needham
    Buy

    Institutional Ownership

    Screeners with NRIX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Earnings today
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Nurix Therapeutics, Inc.?
    • Does Nurix Therapeutics, Inc. pay dividends?
    • What sector is Nurix Therapeutics, Inc. in?
    • What industry is Nurix Therapeutics, Inc. in?
    • What country is Nurix Therapeutics, Inc. based in?
    • When did Nurix Therapeutics, Inc. go public?
    • Is Nurix Therapeutics, Inc. in the S&P 500?
    • Is Nurix Therapeutics, Inc. in the NASDAQ 100?
    • Is Nurix Therapeutics, Inc. in the Dow Jones?
    • When was Nurix Therapeutics, Inc.'s last earnings report?
    • When does Nurix Therapeutics, Inc. report earnings?

    What is the ticker symbol for Nurix Therapeutics, Inc.?

    The ticker symbol for Nurix Therapeutics, Inc. is NASDAQ:NRIX

    Does Nurix Therapeutics, Inc. pay dividends?

    No, Nurix Therapeutics, Inc. does not pay dividends

    What sector is Nurix Therapeutics, Inc. in?

    Nurix Therapeutics, Inc. is in the Healthcare sector

    What industry is Nurix Therapeutics, Inc. in?

    Nurix Therapeutics, Inc. is in the Biotechnology industry

    What country is Nurix Therapeutics, Inc. based in?

    Nurix Therapeutics, Inc. is headquartered in United States

    When did Nurix Therapeutics, Inc. go public?

    Nurix Therapeutics, Inc.'s initial public offering (IPO) was on July 24, 2020

    Is Nurix Therapeutics, Inc. in the S&P 500?

    No, Nurix Therapeutics, Inc. is not included in the S&P 500 index

    Is Nurix Therapeutics, Inc. in the NASDAQ 100?

    No, Nurix Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Nurix Therapeutics, Inc. in the Dow Jones?

    No, Nurix Therapeutics, Inc. is not included in the Dow Jones index

    When was Nurix Therapeutics, Inc.'s last earnings report?

    Nurix Therapeutics, Inc.'s most recent earnings report was on July 10, 2025

    When does Nurix Therapeutics, Inc. report earnings?

    The next expected earnings date for Nurix Therapeutics, Inc. is October 9, 2025
    On this page